Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Key Clinical Message: Pseudohypoaldosteronism (PHA) carries a good prognosis if treated early and appropriately, but some cases can have life-threatening events. We underscored the need to consider secondary PHA as one of the differential diagnoses of hyponatremia and hyperkalemia in infancy.
Abstract: Pseudohypoaldosteronism (PHA) type 1 has two classifications; the primary type, caused by genetic abnormalities that develop during neonatal and infancy periods, and the secondary type, caused by urinary tract malformation and urinary tract infection. Secondary PHA, if treated early and appropriately, has a good prognosis; however, some cases can present life-threatening events. Therefore, early diagnosis is crucial. We present a case of early infancy secondary PHA presented with marked hyponatremia and poor weight gain. The patient's growth and development improved with secondary PHA treatment. Here, were demonstrated the value of prompt action against infection and electrolyte imbalance and the importance of imaging for diagnosis, and underscore the need to consider secondary PHA as a differential diagnoses of hyponatremia and hyperkalemia in infancy. However further studies, including basic research, to elucidate the diseases pathology is warranted.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982118 | PMC |
| http://dx.doi.org/10.1002/ccr3.8722 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Life-Threatening Hyponatremia, Hyperkalemia, and Shock in Infancy: Not Always Congenital Adrenal Hyperplasia.
Cureus
August 2025
Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong, HKG.
Hyponatremia and hyperkalemia, though uncommon in infancy, are potentially life-threatening electrolyte disturbances. We discuss a case of secondary pseudohypoaldosteronism (PHA) in a six-month-old male presenting with recurrent vomiting, severe hyponatremia (119 mmol/L), hyperkalemia (6.6 mmol/L), and metabolic acidosis (bicarbonate: 9 mmol/L).
View Article and Find Full Text PDFImmune Reconstitution and Need for Booster Vaccinations Among Non-Transplant Childhood Cancer Survivors: A Single-Center Experience.
Cancer Rep (Hoboken)
September 2025
Baylor College of Medicine, Houston, Texas, USA.
Background: Waning immunity from childhood vaccines can be more profound in pediatric patients following chemo/immunotherapy. Moreover, childhood cancer survivors (CCS) are at significantly increased risk for life-threatening infections. We implemented an institutional standard of practice (SOP) to assess immune reconstitution and provide recommendations for re-vaccination for non-transplant CCS.
View Article and Find Full Text PDFMicroRNA-301a directly targets IL-4/13A to negatively regulate Th2 immune responses in large yellow croaker (Larimichthys crocea).
Dev Comp Immunol
August 2025
State Key Laboratory of Mariculture Breeding, Key Laboratory of Marine Biotechnology of Fujian Province, College of Marine Sciences, College of Life Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, China. Electronic address:
Interleukin-4 (IL-4) and IL-13, predominantly secreted by T helper type 2 (Th2) cells, are pivotal cytokines involved in the Th2 response via the MAPK and mTOR signaling pathways. MicroRNAs (miRNAs) modulate various biological processes by inhibiting mRNA translation or facilitating mRNA degradation. However, research on miRNAs targeting IL-4 and IL-13 and their associated downstream signaling molecules remains limited.
View Article and Find Full Text PDFAnalysis and optimization of polyhydroxyalkanoates production by environmental bacterial isolates from Nepal.
BMC Microbiol
August 2025
Department of Microbiology, St. Xavier's College, Maitighar, Kathmandu, 44600, Nepal.
The versatile non-biodegradable material plastic has significantly enhanced innovation, but its production heavily relies on fossil fuels and non-renewable resources, which causes severe pollution and ecosystem disruption, highlighting the urgent need for eco-friendly alternatives. Polyhydroxyalkanoates (PHA) are a class of bioplastics that offer a promising solution as biodegradable, environmentally compatible, and versatile biopolymer synthesized by microorganisms using various substrates, aiding in organic waste management. This study was aimed to isolate and profile PHA producing bacteria from diverse sources such as soil, compost, landfill site, and sewage in Nepal.
View Article and Find Full Text PDFSeralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
Adv Ther
August 2025
Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
Introduction: Seralutinib is an inhaled tyrosine kinase inhibitor targeting platelet-derived growth factor receptor (PDGFR) α/β, colony stimulating factor 1 receptor (CSF1R), and mast/stem cell growth factor receptor kit (c-KIT) kinases. TORREY, a phase 2, double-blind, randomized, placebo-controlled study of seralutinib in pulmonary arterial hypertension (PAH), met its primary endpoint, demonstrating a significant reduction in pulmonary vascular resistance (PVR) over placebo after 24 weeks (NCT04456998; EudraCT 2019-002669-37). We present results (as of December 5, 2024) from an open-label extension (OLE) study evaluating long-term safety, tolerability, and efficacy of seralutinib in adults with PAH (NCT04816604).
View Article and Find Full Text PDF